Drug Policy Network SEE
  • Home
  • About Us
  • Publications
    • Newsletter
    • Documents
  • Calendar
  • News
  • Contact
  • Our publications
  • Search

Pompidou Group

Posts

Executive Training on gender dimensions in drug policy

22/01/2019/in News /by DPNSEE Office

Pompidou Group – the Council of Europe’s drug policy cooperation platform – organises an Executive Training on gender dimensions in drug policy. The purpose of the training is to assist managers responsible for the implementation of drug policies and programmes to effectively integrate gender perspectives and dimensions into all aspects of their work from planning strategic tools, developing normative standards, designing and delivering thematic and regional programmes and working through the project cycle.

The training is tailored for managers from governmental or other institutions and organisations responsible for developing and/or implementing drug policies and/or coordinating related programme implementation, service delivery and cooperation with stakeholders and representatives from civil society organisations working in various sectors of drug field.

The training course consists of the two modules that are conducted during two in-residence seminars:

  • 1st Module: Seminar – Setting the scene, to be held 2 – 4 April 2019 in Amsterdam
  • 2nd Module: Seminar – From practice to reflection, scheduled for 25 – 28 June 2019 in Israel

The application deadline is 10 February 2019. To apply for the Training, please contact the Permanent Correspondent of your country or the Secretariat of the Pompidou Group.

A brochure about the training is available following this link>>>>

If interested, have a look at the video bellow

http://www.dpnsee.org/cms/files/2019/01/Pompidou-Group-Executive-Training.jpg 723 1000 DPNSEE Office /cms/files/2015/11/logo.png DPNSEE Office2019-01-22 08:45:272019-01-22 01:50:25Executive Training on gender dimensions in drug policy

Tuesday, 13 March – second CND day

14/03/2018/in News /by DPNSEE Office

Side events

Use of social marketing in promoting online interventions

The event offered by the Governments of Croatia and Finland, the Pompidou Group of the Council of Europe and the United Nations Office on Drugs and Crime Prevention, Treatment and Rehabilitation Section.

Chair of the session was Elena Hedoux, Programme Manager of the Pompidou Group of the Council of Europe; opening remarks were given by Gilberto Gerra, Chief of Drug Prevention and Health Branch, UNODC and speakers were Mirka Vainikka, Executive Director of “Free from Drugs“, Thomas Kattau, Deputy Executive Secretary of the Pompidou Group of the Council of Europe and Marko Markus from the Office for Combating Drugs Abuse of the Government of the Republic of Croatia.

Interesting points from the presentations include:

  • Gilberto Gerra: Instead of selling something, companies work on changing behaviour. It doesn’t end with companies speaking only to customers, but customers start speaking with each other. We need to explore how to reach psychonauts 2 (an upcoming platform video game being built on the success of a classic action/adventure platformer; it is an example of a crowdfunding campaign to create a sequel of the success of the initial game)
  • Thomas Kattau: If you invest in on-line tools, you need to invest in marketing these tools. Companies have much more money to invest into (social) marketing than public institutions (not to talk about civil society – our comment).
  • Marko Markus: presented the work of the Office using a Facebook webpage and a special page drughelp.eu. He underlined that 90% of people who are in need never asked for help!

All presentations of the event are available following this link. More about the event is already available from a special web page prepared by the Office.

Drugs and the darknet

The Government of Bulgaria and the European Union hosted the event to discuss connection between drugs and darknet, a largely anonymous platform for trading a range of illicit goods and service. Chair of the event Svetoslav Spassov, Permanent Representative of Bulgaria to the UN introduced the issue reminding participants that it is estimated that around 2/3 of the offers on darknet are drug related. The accessibility and quick adaptability of on-line markets pose a growing threat.

Alexis Goosdeel, EMCDDA Director presented facts from the recent report which shows extreme growth of criminal actions on Internet and darknet especially. EMCDDA discovered in several cases that what was sold was what was promoted. There is a good system of rating the products and sellers. Most of the traffic are done in Germany, UK and The Netherlands. Most of the products are non-cocaine stimulants and new psychoactive substances. Alphabay grew very fast since creation in December 2014 and in two years traffic there was twice bigger than the one of the pioneer Silk Road (which was closed by law enforcement in 2017). Due to anonymity, there is no wholesale at darknet because of the risk connected.

Liamonas Vasiliauskas from the Operations Directorate, Europol confirmed that many vendors offer a variety of drugs. Monthly revenue of 8 major criminal groups on darknet is 10 – 12 million Euro. What Europol don’t know are drug sources, chemicals and equipment, money flows, role of organised crime, etc. Due to darknet, regular post package services grew significantly in recent years. Most of the EU countries don’t have a specific darknet investigation team – Europol designed a model of establishing one. FBI, DEA and Dutch Police closed two networks in operations Bayonet (Silk Road) and GraveSac (Hansa). Europol don’t have information if this seizure of networks caused decrease of traffic or the market quickly recovered.

Peter Mihoc from the European Commission added that one of the main issues is the knowledge gap. Another is lack of equipment needed for operations of law enforcement agencies.

Law enforcement and sustainable drug use prevention

The event was chaired by John Redman, Society for the Advancement of Global Understanding, while panelists included commander Juan Antonio Cano Carrasco, representative of the Spanish Army, Angelo Lange, local law enforcement in Milano, Italy, Dr Christian Mirre, biologist, Foundation for a Drug Free Europe.

Interesting points from the presentations include:

  • John Redman: Spoke about a success of fighting meth problem in Southern California in cooperation between law enforcement and people from communities, including those from Mexico.
  • Juan Antonio Cano Carrasco: They operate as the part of society – and respond to the needs of it. Army is included in the national action plan against drugs. All three Army (VID) are involved: infantry, navy and air forces and coordination is typical army one. Most efforts invest in prevention, working towards a drug free world. Drug tests are performed when joining the army but also regularly, both to officer and all the military (all army is professional). They also have a program of informing their military. They invest in creating a favourable environment so that they don’t get interest to use drugs. One element of the programme is cooperation with communities, on all levels, which includes training, information sharing and free time activities of the military.
  • Angelo Lange: Drug is being sold by people of all different kinds. Milano experienced a dramatic increase of cocaine traffic in 2007. National Police created a special unit, who were not in uniforms to fight the problem in every possible environment. They made a success thanks to anonymous reports from citizens and trust they built with people, including drug users. On contrary they do prevention in a social context. He published a book “Life in dust: drogues, fuck you” in 2010 and a year earlier he recorded a movie “Sbiri” (Caps, in slang). In 2016, a mural was created through a competition of teams reflecting on his book. Also, a theatrical play was set on the basis of his and another author.
  • Christian Mirre: 1.117 US Police departments adopted a partnership program on drug prevention. The same happened in the Czech Republic, South Africa and several other countries. They prepared a curriculum package material translated already in 17 languages.

Other side events

Notes about some interesting side events are available:

  • World Drug Report: Latest trends and addressing users’ needs
  • Public health dimensions of the world drug problem and WHO activities in addressing them
  • Modernizing drug policy: What helps and what goes against it – case studies
  • NGO briefing on the Annual Report Questionnaire

 

http://www.dpnsee.org/cms/files/2018/03/13-Side-event-A-2.jpg 563 1000 DPNSEE Office /cms/files/2015/11/logo.png DPNSEE Office2018-03-14 09:13:112018-03-23 00:41:52Tuesday, 13 March - second CND day

CND opening day

13/03/2018/in News /by DPNSEE Office

NGO briefing by the Vienna NGO Committee

The briefing was a useful orientation, especially for the newcomers, to what will happen and the annual UN Commission on Narcotic Drugs and the role and involvement of civil society organisations.

Opening of the sixty-first CND Session

The opening session was held in plenary, with all national delegations and civil society representatives present and transmitted to other rooms. It included welcome messages of the CND 61 Chairperson Alicia Buenrostro Massieu, UN Secretary-General António Guterres, International Narcotics Control Board President Dr Viroj Sumyai, UNODC Executive Director Yuri Fedotov, WHO Director – General Tedros Adhanom Ghebreyesus and introductory speeches of country groupings: Group of 77 and China, Africa Group, Asia Pacific Group, Latin American and Caribbean Group (GRULAC) and European Union Group (including accession countries). The Session then continues with general debate.

It should me mentioned that Deputy Minister of Health of Bulgaria Svetlana Yordanova spoke on behalf of the European Union (Bulgaria holds presidency of the EU). She underlined that current UN Drugs Policy has been an utter failure and that EU expresses deepest regret that the UNGASS Outcome Document does not mention a moratorium on the death penalty. She said that “In 2009, we set 2019 as a target date for ourselves to eliminate cultivation of opium, coca and cannabis plants and social risks, trafficking and money laundering related to illicit drugs. We have not achieved this target: today we have an equally severe and diversified situation. The problems are evolving. We have never seen such a complex set of challenges in the drug area: NPS, the internet, trafficking, new players and increased production. EU supports bringing public health and human rights to the core of the drug policy by balancing law enforcement with equally firm health and social services and evidenced based actions.

Side events

Bringing human rights to the forefront of drug policy: Development, implementation, monitoring and evaluation

The event was organised by the governments of Malta (represented by Ambassador Keith Azzopardi), Germany (Ambassador Friedrich Dauble), Norway, the Pompidou Group of the Council of Europe (Jan Malinowski, Executive Secretary). Speakers were also Damon Barrett, Director of the International Centre on Human Rights and Drug Policy, University of Essex and Zaved Mahmoud, Office of the UN High Commissioner for Human Rights. This event was an attempt to move beyond highlighting human rights problems by examining the impact of the world drug problem on the enjoyment of human rights and exploring the application of human rights standards and tests as a basis for national and local led initiatives to incorporate human rights into drug policy development, monitoring and evaluation.

In the outcome document of the 2016 UNGASS on the world drug problem, UN member states reiterated a “commitment to respecting, protecting and promoting all human rights fundamental freedoms and the inherent dignity of all individuals and the rule of law in the development and implementation of drug policies”. In drug policy – as in all other policy areas – human rights are not a choice, they are an obligation.

Interesting points from the presentations include:

  • Human rights start in small places, close to home – Eleanor Roosevelt
  • Jan Malinowski: There is no discussion about death penalty and extrajudicial killings. CoE is condemning inhuman treatments. There must be mechanisms in place to bring to light rights issues arising from drug policy
  • Damon Barrett: There is no universal prescription due to diversity in country situations, but we have universal standards! The challenge for policy makers is to resolve the tension between human rights and drug policy in favour of human rights. Health services should be available, accessible, acceptable (by different populations) and of sufficient quality. Consider harm reduction in funding decisions.
  • Zaved Mahmood: Wrong policy decisions influence various segments of life. For instance, punishing legislation leads to overcrowded prisons. Until we address the human dimension of drug policies, those policies will fail.

The world drug perception problem

This event was organized by the Governments of Portugal, Switzerland and Uruguay and the Global Commission on Drug Policy to discuss the current perceptions but also progress already made in some countries to fight negative perceptions, stigma, discrimination and criminalization of people who use drugs, as well as possible further steps.

Speakers included Pavel Bém, Commissioner, Global Commission on Drug Policy (GCDP), Michel Kazatchkine, UN Special Envoy on HIV/AIDS for Eastern Europe and Central Asia, João Goulão, National Drug Coordinator, Portugal, Martín Rodríguez, Executive Director of the Institute for the Regulation and Control of Cannabis (IRCCA), Uruguay, Nora Kronig-Romero, Ambassador for Global Health, Switzerland and Judy Chang, Executive Director, INPUD.

The latest GCDP report on the issue The World Drug Perception Problem: Countering Prejudices About People Who Use Drugs was published in 2017.

Interesting points from the presentations include:

  • Michel Kazatchkine: presented an interesting fact from the report that “UNODC estimates only 11.6% of those who used drugs in 2016 are considered to suffer problematic drug use or addiction. The most common pattern of drug use is episodic and non-problematic.” and that “Legal status of #drugs rarely correspond to potential harms, not based on scientific evidence.”
  • Martín Rodriguez: “There have been no episodes of violence between the people who use or in the surroundings of the sale places” (in Uruguay, who legalised sale of cannabis) and “Before the sale of recreational cannabis in pharmacies started, almost ¾ were against it; 6 months later and due to the positive experiences, this has fallen to 43%”
  • Nora Kronig-Romero: The main factors leading the Swiss population to approve drug policy reform was failure of law enforcement only approach and experiences with small projects of harm reduction. Direct democracy contributed to an informed discussion about drugs, drug perception and drug policy in Switzerland.
  • João Goulão: “Problematic drug use reached all parts of society and that led to a change in the popular view of drug use – changing perceptions about people who use drugs”
  • Judy Chang – We don’t believe in reducing a behaviour to an identity. We prefer the phrase “people who use drugs” to more stigmatising language but emphasise drug dependency is not incompatible with a person living a happy and fulfilled lives

A note from this side event is available at the CND blog.

http://www.dpnsee.org/cms/files/2018/03/12-CND-Opening.jpg 477 723 DPNSEE Office /cms/files/2015/11/logo.png DPNSEE Office2018-03-13 01:47:082018-03-13 10:47:39CND opening day

Treatment Systems in Prisons in Eastern and Southeastern Europe

23/09/2017/in News /by DPNSEE Office

Pompidou Group – Council of Europe Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs, published a new publication “Drug Treatment Systems in Prisons in Eastern and Southeastern Europe”. The publication sheds light into the situation of drug users among criminal justice populations and corresponding health care responses in ten countries in Eastern and Southeastern Europe: Albania, Bosnia-Herzegovina, Georgia, Kosovo*, Macedonia, Moldova, Montenegro, Russia, Serbia, and Ukraine.

Prisons differ across different countries, as do prisoner populations. In some of the countries in the study there is an almost complete unavailability of effective drug dependence treatment (e.g. Opiate Agonist Treatment), or the potential of these treatment has not been exploited yet to its full. But also models of good practice exist in a few of the researched countries.

The publication is a product of the Pompidou Group of the Council of Europe project “Improving Drug Treatment Systems in prisons” which was financed by Luxembourg.

DPNSEE Chairperson Tijana Žegura and Secretary of the Board Denis Dedajić contributed to the publication.

Those interested in downloading the publication should follow this LINK>>>

http://www.dpnsee.org/cms/files/2017/09/Pompidu-publication.jpg 1914 2480 DPNSEE Office /cms/files/2015/11/logo.png DPNSEE Office2017-09-23 01:03:592017-09-23 01:03:59Treatment Systems in Prisons in Eastern and Southeastern Europe

Search

Categories

  • News
  • News from Member Organisations
  • Newsletter
  • Press releases
Drug Policy Network SEE
Tweets by DPN_SEE
© Copyright - Drug Policy Network SEE
  • Facebook
  • Twitter
  • Home
  • About Us
  • Publications
  • Calendar
  • News
  • Contact
  • Our publications
Scroll to top